Electronic Trial Master File (eTMF)

Electronic Trial Master File (eTMF) is the category of software systems used to create, store, version-control, and track the completeness of a clinical trial’s Trial Master File (TMF) in electronic form, in place of paper binders. Where the TMF is the content — the organized set of essential documents ICH E6(R2) Section 8 requires — the eTMF is the system that holds that content: the platform a sponsor, CRO, or site uses to upload, classify, version, quality-check, and report on those documents throughout the trial.

What makes something an eTMF (not just a document repository)

A generic document-sharing or file-storage system is not an eTMF just because it holds TMF documents. An eTMF specifically provides:

• Structure against a reference taxonomy. Documents are classified against a defined artifact list — almost universally the industry-developed TMF Reference Model (originally a Drug Information Association initiative, now maintained under CDISC), which organizes TMF content into functional zones such as Trial Management, Regulatory, Investigational Product, Safety Reporting, and Site Management — rather than an ad hoc folder structure each study or site invents on its own.
• Expected-document tracking and real-time completeness metrics. The system is built around an expected-document list (sometimes called an EDL) for the trial — the specific artifacts that should exist for this protocol, this country, this site — and continuously compares what has actually been filed against that list, surfacing completeness and filing-timeliness as a live percentage or dashboard rather than something calculated manually before an audit.
• Quality control workflow. Uploaded documents move through review/QC steps — often risk-based, applying more scrutiny to higher-risk document types — before being marked final, with the outcome of that review itself becoming part of the auditable record.
• Version control and an audit trail. Every upload, edit, approval, and reclassification is time-stamped and attributable, so the system can show not just the current state of the TMF but its complete history — who filed what, when, and what changed.
• Validated, access-controlled infrastructure. Because eTMF documents are the electronic form of records that ICH GCP and FDA predicate rules already require sponsors and investigators to keep, an eTMF used for FDA-regulated trials generally falls within 21 CFR Part 11‘s scope for electronic records and signatures — requiring a validated system, role-based access, and (where used) attributable electronic signatures.

eTMF vs. TMF: system vs. content

The distinction mirrors how CASRAI distinguishes Electronic Data Capture (EDC) from a Clinical Trial Management System (CTMS): two adjacent categories that are easy to conflate because they’re used together. The TMF is the regulatory concept and the content requirement — the set of essential documents ICH E6(R2) Section 8 says must exist, regardless of medium. The eTMF is one specific implementation choice for holding that content: a purpose-built software platform, frequently offered as a standalone product or as a module of a broader CTMS suite. A trial can technically have a compliant TMF in paper binders (now rare in practice) or a non-compliant, disorganized eTMF instance that technically runs on software but fails to meet the completeness and quality bar — having the software does not, by itself, guarantee a compliant TMF; the software has to actually be used and maintained correctly throughout the trial.

Why the completeness dashboard matters for inspection readiness

The operational value sponsors and CROs cite most often for eTMF adoption is that TMF completeness stops being a retrospective, manual exercise. Rather than staff reconstructing what’s missing shortly before a regulatory inspection, an eTMF’s dashboard shows completeness and filing-timeliness continuously, at the trial, country, or site level, so gaps are visible and addressable while the trial is still running. This is the direct, practical link between eTMF adoption and inspection readiness: FDA, EMA, and other authorities treat TMF completeness and quality as direct evidence of GCP compliance, and a system that makes that status visible in real time—rather than only discoverable through a manual audit—is what lets a study stay continuously inspection-ready instead of racing to assemble one before an announced inspection.

Examples

eTMF is a functional software category with both large enterprise platforms and CTMS-bundled modules, not one specific product:

• Veeva Vault eTMF — a widely used standalone eTMF platform built around expected-document-list tracking, a real-time completeness dashboard, and risk-based document QC workflows, commonly used by sponsors and CROs running regulated trials.
• PhlexTMF (Cencora/Phlexglobal) — another established enterprise eTMF platform offering study-, country-, and site-level completeness dashboards and structured quality-review workflows.

Several broader CTMS suites also bundle an eTMF module rather than requiring a separate standalone product; the underlying functional requirements (Reference Model structure, completeness tracking, QC workflow, audit trail, Part 11 validation) are the same regardless of whether the eTMF is sold standalone or as part of a larger suite.

Counter-example

A shared network drive or generic cloud file-storage folder holding scanned TMF documents is not an eTMF, even though the documents are technically stored electronically. Without classification against a reference taxonomy, an expected-document list to compare against, QC workflow, version-controlled audit trail, and validated access controls, it cannot produce a real-time completeness picture or satisfy Part 11 expectations — it is simply an electronic filing cabinet, functionally closer to the paper-binder model than to a true eTMF.

Related terms

• Trial Master File (TMF) — the content and regulatory concept an eTMF holds.
• Inspection Readiness — the compliance outcome real-time eTMF completeness tracking supports.
• 21 CFR Part 11: Electronic Records & Signatures — the FDA regulation shaping eTMF validation, audit-trail, and e-signature requirements.
• Electronic Data Capture (EDC) — the analogous system/content distinction on the research-data side of a trial.
• Clinical Trial Management System (CTMS) — the trial-operations platform an eTMF is sometimes bundled with.

Frequently asked questions

Is eTMF the same thing as TMF?

No. TMF is the regulatory content requirement — the set of essential documents ICH E6(R2) Section 8 requires a trial to maintain. eTMF is the software system used to store, organize, and track that content electronically. A trial has one TMF (or, more precisely, a sponsor TMF plus each site’s Investigator Site File); the eTMF is the tool used to manage it.

Does using an eTMF automatically make a trial inspection-ready?

No. An eTMF makes completeness and quality status visible and trackable in real time, which makes staying inspection-ready far more achievable, but the sponsor, CRO, and sites still have to actually file documents promptly, resolve QC findings, and keep the system current throughout the trial. The software provides the capability; the team’s ongoing use of it produces the compliant record.

Is an eTMF the same as a CTMS?

No. An eTMF manages TMF documents and completeness status. A CTMS manages broader trial operations — site contracts, monitoring visit tracking, enrollment. Some vendors bundle eTMF as a CTMS module; others sell it as a standalone platform. The two solve different problems even when sold together.

What is the TMF Reference Model, and do all eTMFs use it?

The TMF Reference Model is an industry-developed taxonomy (originally a DIA initiative, now maintained under CDISC) that organizes TMF/eTMF content into functional zones and artifacts. Most commercial eTMF platforms are structured around it, since a shared reference structure makes a TMF portable across CROs and vendor systems and makes completeness auditable against a known artifact list rather than an informal, study-specific checklist — but using the Reference Model is a strong industry convention, not itself a regulatory mandate.

See also: Clinical Research Administration, the broader CASRAI cluster this term sits within.